Oct

26

2021

Should patients with heparin-induced thrombocytopenia (HIT) be administered anti-platelet agents

By William Aird

A

Should patients with heparin-induced thrombocytopenia (HIT) be administered anti-platelet agents

No, not unless there is another indication for these drugs, for example a coronary stent, and provided the risk: benefits are acceptable.

2018 ASH guideline

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.